PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Departments of Endocrinology, Changhai Hospital, The Second Military Medical University, Shanghai 200433, China; Deparment of Infectious Disease, Guanggu District, Hubei Province Maternal and Child Health Care Hospital, Wuhan 430200, China.\', \'Deparment of Infectious Disease, Guanggu District, Hubei Province Maternal and Child Health Care Hospital, Wuhan 430200, China; Department of Aviation Disease, Naval Medical Center of PLA,The Second Military Medical University, Shanghai 200052,China.\', \'Deparment of Infectious Disease, Guanggu District, Hubei Province Maternal and Child Health Care Hospital, Wuhan 430200, China; Department of Neurosurgery, Changhai Hospital, The Second Military Medical University, Shanghai 200433, China.\', \'Deparment of Infectious Disease, Guanggu District, Hubei Province Maternal and Child Health Care Hospital, Wuhan 430200, China; Departments of Cardiology, Changhai Hospital, The Second Military Medical University, Shanghai 200433, China.\', \'Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610041,China.\', \'Shanghai Institute of Hypertension, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.\', \'Department of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430022,China.\', \'Division of Nephrology and Hypertension, University Hospital Lausanne (CHUV) , Lausanne CH-1011, Switzerland.\', \'Deparment of Infectious Disease, Guanggu District, Hubei Province Maternal and Child Health Care Hospital, Wuhan 430200, China; Department of Respiratory and Critical Care Medicine, Changhai Hospital, The Second Military Medical University, Shanghai 200433, China.\', \'Department of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.\', \'Departments of Cardiology, Fuwai Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100037, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3760/cma.j.cn112138-20200328-00310
?:doi
?:hasPublicationType
?:journal
  • Zhonghua nei ke za zhi
is ?:pmid of
?:pmid
?:pmid
  • 32340096
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • [Preliminary clinical analysis of direct renin inhibitor aliskiren in the treatment of severe coronavirus disease 2019 patients with hypertension].
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32340096>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32340096>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all